Opinion
Video
Exploring the Kidney-CHAMP Study
Key Takeaways
- The trial focused on improving cardiovascular risk management in type 2 diabetes through a coordinated care model involving healthcare systems.
- Interventions included educational sessions, feedback, and support for healthcare providers to enhance adherence to guideline-directed medical therapy.
A panel of experts explores the objectives and design of the COORDINATE-Diabetes trial, discussing its potential impact on the treatment paradigm for diabetes management.
EP: 1.The Impact of CRM Diseases in the US: Burden, Prevalence, and Obesity
EP: 2.Strategies for Prevention and Screening of CRM Conditions
EP: 3.The Link Between Obesity and CRM Conditions
EP: 4.Challenges in Managing Co-Morbid CRM Conditions
EP: 5.Contemporary Guidelines for CRM Conditions
EP: 6.Reasons for Low Adherence to Guidelines for CRM Conditions
EP: 7.Overcoming Barriers to Prescribing First-Line Medications for CRM Conditions
EP: 8.Educational Initiatives to Enhance Guideline Adherence in CRM
EP: 9.Addressing Gaps in CKD, T2D, and CVD Guidelines
EP: 10.Care Coordination for High-Risk CRM Patients
EP: 11.Takeaways from the UH CINEMA Program
Now Viewing
EP: 12.Exploring the Kidney-CHAMP Study
Video content above is prompted by the following:
- Tell us about the COORDINATE-Diabetes trial.
- What were the objectives of COORDINATE-Diabetes and how was the trial designed?
- What interventions were provided?
- What were the results of the study?
- What are future opportunities to improve CRM care based on this trial?
This activity is supported by an educational grant from Boehringer Ingelheim.
Related Videos
Related Content
Published: October 18th 2024 | Updated: October 18th 2024
A Novel Approach to Chronic GVHD With Axatilimab: Dr Daniel Wolff
